FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 31 filers reported holding FENNEC PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $68,018 | -11.8% | 9,057 | +3.7% | 0.00% | – |
| Q2 2023 | $77,130 | -2.4% | 8,735 | -31.1% | 0.00% | – |
| Q1 2021 | $79,000 | -16.0% | 12,685 | +0.3% | 0.00% | – |
| Q4 2020 | $94,000 | +20.5% | 12,651 | -1.0% | 0.00% | – |
| Q3 2020 | $78,000 | -29.1% | 12,785 | -3.2% | 0.00% | -100.0% |
| Q2 2020 | $110,000 | +197.3% | 13,210 | +71.3% | 0.00% | – |
| Q1 2019 | $37,000 | -24.5% | 7,710 | +0.9% | 0.00% | – |
| Q4 2018 | $49,000 | -22.2% | 7,639 | -0.8% | 0.00% | – |
| Q3 2018 | $63,000 | -18.2% | 7,697 | +4.3% | 0.00% | – |
| Q2 2018 | $77,000 | – | 7,381 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Solas Capital Management, LLC | 849,979 | $3,400,000 | 3.47% |
| Southpoint Capital Advisors LP | 3,997,214 | $15,989,000 | 0.60% |
| Opaleye Management Inc. | 295,000 | $1,180,000 | 0.36% |
| 683 Capital Management, LLC | 971,351 | $3,885,000 | 0.35% |
| Avoro Capital Advisors LLC | 1,105,999 | $4,424,000 | 0.15% |
| Eventide Asset Management | 720,000 | $2,880,000 | 0.09% |
| Granahan Investment Management | 439,083 | $1,756,000 | 0.09% |
| Hartford Financial Management Inc. | 20,300 | $81,000 | 0.03% |
| OXFORD ASSET MANAGEMENT LLP | 75,236 | $301,000 | 0.01% |
| Paloma Partners Management Co | 54,400 | $218,000 | 0.00% |